BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35012441)

  • 41. Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin.
    Yan T; Deng S; Metzger A; Gödtel-Armbrust U; Porter AC; Wojnowski L
    Mol Cancer Ther; 2009 May; 8(5):1075-85. PubMed ID: 19417146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.
    Yan Z; Wang J; Wang C; Jiao Y; Qi W; Che S
    FEBS Lett; 2014 Aug; 588(17):3038-46. PubMed ID: 24931370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.
    Mitrović O; Čokić V; Đikić D; Budeč M; Vignjević S; Subotički T; Gulan M; Radović S; Furtula S
    Target Oncol; 2014 Dec; 9(4):367-79. PubMed ID: 24272208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.
    Deguchi S; Katsushima K; Hatanaka A; Shinjo K; Ohka F; Wakabayashi T; Zong H; Natsume A; Kondo Y
    Oncogene; 2017 Aug; 36(32):4629-4640. PubMed ID: 28368417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands.
    Bossaert M; Pipier A; Riou JF; Noirot C; Nguyên LT; Serre RF; Bouchez O; Defrancq E; Calsou P; Britton S; Gomez D
    Elife; 2021 Jun; 10():. PubMed ID: 34180392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TOPBP1 recruits TOP2A to ultra-fine anaphase bridges to aid in their resolution.
    Broderick R; Nieminuszczy J; Blackford AN; Winczura A; Niedzwiedz W
    Nat Commun; 2015 Mar; 6():6572. PubMed ID: 25762097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
    Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M
    Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
    Zhang B; Fang S; Cheng Y; Zhou C; Deng F
    Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.
    Romero A; Martín M; Cheang MC; López García-Asenjo JA; Oliva B; He X; de la Hoya M; García Sáenz JÁ; Arroyo Fernández M; Díaz Rubio E; Perou CM; Caldés Llopis T
    Am J Pathol; 2011 Apr; 178(4):1453-60. PubMed ID: 21435434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway.
    Gong X; Huang M
    Cancer Gene Ther; 2017 Sep; 24(9):381-385. PubMed ID: 29027534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expression.
    Kiakos K; Satam V; Patil PC; Sweers J; Bowerman M; Tzou S; Olsen K; Lee M; Schaschl H; Keppler BK; Hochhauser D; Lee M; Hartley JA; Pett L
    Bioorg Med Chem Lett; 2021 Sep; 47():128158. PubMed ID: 34058343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.
    Norimura S; Kontani K; Kubo T; Hashimoto SI; Murazawa C; Kenzaki K; Liu D; Tamaki M; Aki F; Miura K; Yoshizawa K; Tangoku A; Yokomise H
    J Cancer Res Ther; 2018; 14(2):409-415. PubMed ID: 29516929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing.
    Herrero-Ruiz A; Martínez-García PM; Terrón-Bautista J; Millán-Zambrano G; Lieberman JA; Jimeno-González S; Cortés-Ledesma F
    Cell Rep; 2021 Apr; 35(2):108977. PubMed ID: 33852840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of the C-Terminal Region on the Interaction of Topoisomerase II Alpha with Mitotic Chromatin.
    Antoniou-Kourounioti M; Mimmack ML; Porter ACG; Farr CJ
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
    Zhang L; Liu H; Mu X; Cui J; Peng Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.
    Kirk JS; Schaarschuch K; Dalimov Z; Lasorsa E; Ku S; Ramakrishnan S; Hu Q; Azabdaftari G; Wang J; Pili R; Ellis L
    Oncotarget; 2015 Feb; 6(5):3136-46. PubMed ID: 25605014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone H2A phosphorylation recruits topoisomerase IIα to centromeres to safeguard genomic stability.
    Zhang M; Liang C; Chen Q; Yan H; Xu J; Zhao H; Yuan X; Liu J; Lin S; Lu W; Wang F
    EMBO J; 2020 Feb; 39(3):e101863. PubMed ID: 31769059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mining topoisomerase isoforms in gastric cancer.
    Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
    Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer.
    de Resende MF; Vieira S; Chinen LT; Chiappelli F; da Fonseca FP; Guimarães GC; Soares FA; Neves I; Pagotty S; Pellionisz PA; Barkhordarian A; Brant X; Rocha RM
    J Transl Med; 2013 Feb; 11():36. PubMed ID: 23398928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.